July 2011 - Safety Study of Dabigatran in CADASIL

This study is a Phase II, randomized, crossover trial designed to compare one fixed dose of dabigatran with open-label use of ASA in patients affected by CADASIL;  Study Chair: Francesco Orzi, MD, NESMOS Department, University of Rome "La Sapienza"; St. Andrea Hospital, Italy.


Italy – CLOSED

NESMOS Department St. Andrea Hospital 
Rome, Italy, 00189 
Contact: Francesco Orzi, MD +39-06-33775829 
Contact: Giulio Caselli, MD +39-347-8654946 
Principal Investigator: Giulio Caselli, MD 
Principal Investigator: Barbara Casolla, MD 

Emergency Department Stroke Unit, Umberto I Hospital 
Rome, Italy, 00161 
Contact: Danilo Toni, MD +39-06-49979595 
Contact: Agata Correnti, MD 
Principal Investigator: Emanuele Puca, MD 
Francesco Orzi, MD , NESMOS Department, University of Rome "La Sapienza"; 
St. Andrea Hospital